<pre>&#10;____________________________________________________________________________ &#10; &#10;     The following is a list of insider sales with a total value of at &#10;least $250,000 reported to the Securities and Exchange Commission late &#10;Wednesday and early Thursday. &#10; &#10; &#10;Company - (Symbol) Security &#10; Insider                        Date(s)          Shares   Price     Holdings &#10;____________________________________________________________________________ &#10; &#10;ACI Worldwide Inc (ACIW) &#10; Peters Charles E Jr (D)         3/3/25           12,940   $57.57      80,842 &#10; &#10;Advanced Energy Industries Inc (AEIS) &#10; Acebedo Eduardo Bern (COO       3/3/25           19,309  $111.61      19,822 &#10; &#10;Akamai Technologies Inc (AKAM) &#10; Karon Adam (COO)                3/4/25            6,431   $80.49      14,310 &#10; &#10;Akero Therapeutics Inc (AKRO) &#10; Young Jonathan (COO)            3/4/25           50,000   $44.86     261,147 &#10; &#10;Amazon.com Inc (AMZN) &#10; Herrington Douglas J (O)        3/3/25            2,500  $213.17     518,557 &#10; &#10;Amneal Pharmaceuticals Inc (AMRX) CL A &#10; Patel Gautam (D)                3/3/25           80,000    $8.90   1,808,886 &#10; &#10;Analog Devices Inc (ADI) &#10; Roche Vincent (CB)              3/3/25           10,000  $232.62     100,326 &#10; &#10;APi Group Corp (APG) &#10; Ashken Ian G H (D)              3/3/25          200,000   $37.84   5,997,501 &#10; Lillie James E (CB)             3/3/25          250,000   $37.97   6,338,326 &#10; &#10;Arista Networks Inc (ANET) &#10; Giancarlo Charles H (D)         3/3/25            8,000   $89.03     366,576 &#10; Taxay Marc (VP)                 3/3/25           51,848   $88.59           0 &#10; &#10;Arrowhead Pharmaceuticals Inc (ARWR) &#10; Anzalone Christopher (CB)   3/3/25-3/4/25       300,000   $17.58   3,773,802 &#10; &#10;Axis Capital Holdings Ltd (AXS) &#10; Davis Charles A (D)             3/5/25        2,139,037   $93.50   2,465,012 &#10; &#10;Badger Meter Inc (BMI) &#10; Bockhorst Kenneth (CB)      3/3/25-3/4/25         2,751  $210.61      51,034 &#10; &#10;Baldwin Insurance Group Inc (BWIN) CL A &#10; Baldwin Lowry (CB)          3/3/25-3/4/25       125,000   $39.56           0 &#10; &#10;Bentley Systems Inc (BSY) CL B &#10; Ballard Brock (O)               3/3/25            7,684   $43.26      65,642 &#10; &#10;Catalyst Pharmaceuticals Inc (CPRX) &#10; del Carmen Jeffrey (O)          3/3/25           30,423   $22.89           0 &#10; Elsbernd Brian (O)              3/3/25           62,975   $22.98     188,564 &#10; &#10;Chubb Ltd (CB) &#10; Wayland Joseph F (VP)           3/4/25           10,000  $286.96      77,703 &#10; &#10;Ciena Corp (CIEN) &#10; Smith Gary B (CEO)              3/3/25            6,800   $76.41     398,549 &#10; &#10;Cogent Communications Holdings Inc (CCOI) &#10; Schaeffer David (CB)            3/4/25           60,000   $71.77   4,444,038 &#10; &#10;Confluent Inc (CFLT) CL A &#10; Narkhede Neha (D)               3/3/25           40,000   $30.68      22,034 &#10; Sivaram Rohan (CFO)             3/3/25           11,000   $31.14     701,403 &#10; &#10;Core Scientific Inc (CORZ) &#10; Becker Todd A (D)               3/3/25          134,250   $10.75     195,687 &#10; &#10;CRH Plc (CRH) &#10; Connolly Alan (CFO)             3/3/25           10,680  $102.93      52,341 &#10; Mintern Denis James (CEO)       3/3/25            4,097  $102.93      35,757 &#10; &#10;Cytokinetics Inc (CYTK) &#10; Blum Robert I (CEO)             3/5/25           25,000   $43.23     385,317 &#10; &#10;Datadog Inc (DDOG) CL A &#10; Agarwal Amit (P)                3/5/25           25,000  $114.21      90,505 &#10; Blitzer Adam (COO)              3/4/25           26,232  $113.83     163,250 &#10; &#10;Donaldson Co Inc (DCI) &#10; Oberton Willard D (D)           3/5/25            7,000   $68.22      29,599 &#10; &#10;eBay Inc (EBAY) &#10; Iannone Jamie (CEO)         3/3/25-3/4/25        15,000   $66.19     510,373 &#10; &#10;Elastic NV (ESTC) &#10; Banon Shay (OD)             3/2/25-3/4/25       200,000  $108.32   6,793,117 &#10; &#10;Elevance Health Inc (ELV) &#10; Kendrick Charles Mor (VP)       3/5/25            3,504  $396.30      10,116 &#10; &#10;Essex Property Trust Inc (ESS) &#10; Guericke Keith R (D)            3/3/25            7,298  $315.00      16,118 &#10; Kleiman Angela L (CEO)      3/3/25-3/4/25         5,329  $315.00      13,662 &#10; Morrison Anne (VP)              3/3/25            2,571  $314.79       3,389 &#10; Pak Barbara (CFO)               3/3/25            6,318  $314.79       8,654 &#10; &#10;Exelixis Inc (EXEL) &#10; Haley Patrick J (VP)            3/3/25           10,000   $38.80     375,215 &#10; &#10;Frontier Communications Parent Inc (FYBR) &#10; Harrobin John (VP)              3/3/25           36,000   $36.01      76,523 &#10; &#10;Gaming &amp; Leisure Properties Inc (GLPI) &#10; Demchyk Matthew (VP)            3/5/25            6,419   $50.45      43,201 &#10; &#10;Grindr Inc (GRND) CL A &#10; Balance Austin J (O)            3/3/25           26,305   $18.68     606,266 &#10; &#10;Hippo Holdings Inc (HIPO) CL A &#10; Wand Assaf (CB)                 3/3/25           12,250   $28.90   1,170,331 &#10; &#10;Ibotta Inc (IBTA) CL A &#10; D E Shaw &amp; Co LP (SH)           3/3/25           90,366   $33.36   2,721,777 &#10; &#10;Insmed Inc (INSM) &#10; Lewis William H (CB)            3/3/25           25,580   $77.79     618,610 &#10; &#10;Inspire Medical Systems Inc (INSP) &#10; Ban Randy (VP)                  3/3/25            3,947  $185.84       7,592 &#10; Rondoni John (O)                3/3/25            2,287  $185.60      15,500 &#10; &#10;Intercontinental Exchange Inc (ICE) &#10; Martin Lynn C (O)               3/3/25            4,155  $175.00      59,489 &#10; &#10;Iron Mountain Inc (IRM) &#10; Meaney William L (CEO)      3/3/25-3/4/25       237,402   $89.50     295,650 &#10;*Meaney William L (CEO)      3/3/25-3/4/25       237,402   $89.50     295,650 &#10; &#10;Keurig Dr Pepper Inc (KDP) &#10; Denooyer Mary Beth (O)          3/4/25           12,000   $34.05     187,537 &#10; Gamgort Robert James (CB)       3/4/25          416,000   $34.29   3,983,787 &#10; Stephens Angela A (VP)          3/3/25            7,350   $34.17      74,587 &#10; &#10;Kratos Defense &amp; Security Solutions Inc (KTOS) &#10; Carrai Phillip D (DO)       3/3/25-3/5/25        26,000   $26.37     309,927 &#10; &#10;Life Time Group Holdings Inc (LTH) &#10; Tpg GP A LLC (SH)               3/3/25        7,067,299   $30.13  29,748,906 &#10; &#10;Lincoln Electric Holdings Inc (LECO) &#10; Ansberry Jennifer I (VP)        3/3/25           11,124  $205.21      22,173 &#10; Bruno Gabriel (CFO)             3/3/25            6,682  $203.54      29,927 &#10; &#10;LKQ Corp (LKQ) &#10; Zarcone Dominick P (D)          3/3/25           15,000   $42.32     337,735 &#10; &#10;Madrigal Pharmaceuticals Inc (MDGL) &#10; Dier Mardi (CFO)                3/3/25              774  $323.54       6,914 &#10; &#10;Meta Platforms Inc (META) CL A &#10; Olivan Javier (COO)             3/3/25              608  $673.96     119,398 &#10; &#10;MongoDB Inc (MDB) CL A &#10; Merriman Dwight A (D)           3/3/25            3,000  $270.63   1,713,747 &#10; &#10;Murphy USA Inc (MUSA) &#10; Phillips Jeanne Lind (D)        3/5/25              797  $452.31       2,349 &#10; &#10;NewAmsterdam Pharma Co NV (NAMS) &#10; Kooij Louise Frederi (O)        3/4/25          150,000   $20.37      15,000 &#10; &#10;Newmont Corp (NEM) &#10; Viljoen Natascha (COO)          3/3/25            7,799   $43.71     148,244 &#10; &#10;Nexstar Media Group Inc (NXST) CL A &#10; Mcmillen Charles Tho (D)        3/5/25            2,000  $169.51       4,975 &#10; &#10;nLight Inc (LASR) &#10; Keeney Scott H (CB)             3/4/25           53,511    $8.17   1,267,927 &#10; </pre>&#10;<p>&#10;  (MORE TO FOLLOW) Dow Jones Newswires</p>&#10;<p>&#10;  March 06, 2025 08:44 ET (13:44 GMT)</p>&#10;&#10;<br><br>&#10;<div><p>The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.</p></div>